Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(2.03)
# 2,754
Out of 4,670 analysts
674
Total ratings
33.7%
Success rate
-5.46%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XBIO Xenetic Biosciences | Reiterates: Neutral | n/a | $4.11 | - | 6 | Nov 22, 2024 | |
| KURA Kura Oncology | Maintains: Buy | $32 → $37 | $10.80 | +242.59% | 23 | Nov 21, 2024 | |
| APTO Aptose Biosciences | Maintains: Buy | $7 → $2 | $0.19 | +952.63% | 12 | Nov 20, 2024 | |
| CLDX Celldex Therapeutics | Reiterates: Buy | $80 | $27.02 | +196.08% | 27 | Nov 20, 2024 | |
| CYTK Cytokinetics | Reiterates: Buy | $120 | $49.10 | +144.40% | 36 | Nov 19, 2024 | |
| ESPR Esperion Therapeutics | Reiterates: Buy | $16 | $2.52 | +534.92% | 17 | Nov 19, 2024 | |
| BIOR Biora Therapeutics | Maintains: Buy | $15 → $23 | $1.67 | +1,277.25% | 10 | Nov 18, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $24 → $26 | $1.61 | +1,514.91% | 3 | Nov 18, 2024 | |
| APRE Aprea Therapeutics | Reiterates: Buy | $20 | $2.88 | +594.44% | 12 | Nov 18, 2024 | |
| CMPX Compass Therapeutics | Reiterates: Buy | $10 | $1.49 | +571.14% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $2.09 | +904.78% | 25 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.45 | +175.86% | 22 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.01 | - | 17 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.75 | +433.33% | 15 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.26 | +1,006.19% | 15 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $9.65 | +65.80% | 13 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $77 | $18.62 | +313.53% | 17 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.25 | +211.11% | 13 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.92 | +180.61% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $4.17 | +643.41% | 26 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.45 | +363.77% | 9 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $0.91 | +5,090.50% | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.86 | +594.93% | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $32 | $14.99 | +113.48% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.63 | +242.21% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $157 | $119.19 | +31.72% | 19 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.75 | $3.03 | +89.77% | 16 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $0.28 | +7,451.24% | 10 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $8.55 | +274.27% | 26 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $221 | $190.40 | +16.07% | 22 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $102 | $52.59 | +93.95% | 20 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $0.96 | +1,670.83% | 23 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.44 | +521.12% | 19 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $3.03 | +1,055.12% | 4 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $26.04 | +118.89% | 22 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $7.53 | +391.37% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $117 | $30.20 | +287.42% | 16 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.38 | +656.30% | 9 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.69 | +432.59% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.88 | +420.83% | 14 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $0.54 | +3,571.75% | 10 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $5.10 | +311.76% | 7 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.29 | +2,616.47% | 8 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.21 | +875.13% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.50 | +1,289.16% | 7 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.74 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.83 | +1,648.63% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $3.05 | +883.61% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 → $9 | $12.30 | -26.83% | 2 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.31 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $35.07 | -5.90% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $720 | $16.77 | +4,192.18% | 1 | May 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $4.00 | +1,850.00% | 1 | Mar 24, 2017 |
Xenetic Biosciences
Nov 22, 2024
Reiterates: Neutral
Price Target: n/a
Current: $4.11
Upside: -
Kura Oncology
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $37
Current: $10.80
Upside: +242.59%
Aptose Biosciences
Nov 20, 2024
Maintains: Buy
Price Target: $7 → $2
Current: $0.19
Upside: +952.63%
Celldex Therapeutics
Nov 20, 2024
Reiterates: Buy
Price Target: $80
Current: $27.02
Upside: +196.08%
Cytokinetics
Nov 19, 2024
Reiterates: Buy
Price Target: $120
Current: $49.10
Upside: +144.40%
Esperion Therapeutics
Nov 19, 2024
Reiterates: Buy
Price Target: $16
Current: $2.52
Upside: +534.92%
Biora Therapeutics
Nov 18, 2024
Maintains: Buy
Price Target: $15 → $23
Current: $1.67
Upside: +1,277.25%
Fortress Biotech
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.61
Upside: +1,514.91%
Aprea Therapeutics
Nov 18, 2024
Reiterates: Buy
Price Target: $20
Current: $2.88
Upside: +594.44%
Compass Therapeutics
Nov 15, 2024
Reiterates: Buy
Price Target: $10
Current: $1.49
Upside: +571.14%
Nov 15, 2024
Reiterates: Buy
Price Target: $21
Current: $2.09
Upside: +904.78%
Nov 15, 2024
Reiterates: Buy
Price Target: $4
Current: $1.45
Upside: +175.86%
Nov 15, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.01
Upside: -
Nov 14, 2024
Reiterates: Buy
Price Target: $20
Current: $3.75
Upside: +433.33%
Nov 14, 2024
Reiterates: Buy
Price Target: $25
Current: $2.26
Upside: +1,006.19%
Nov 14, 2024
Reiterates: Buy
Price Target: $16
Current: $9.65
Upside: +65.80%
Nov 14, 2024
Reiterates: Buy
Price Target: $77
Current: $18.62
Upside: +313.53%
Nov 14, 2024
Reiterates: Buy
Price Target: $7
Current: $2.25
Upside: +211.11%
Nov 14, 2024
Reiterates: Buy
Price Target: $11
Current: $3.92
Upside: +180.61%
Nov 14, 2024
Reiterates: Buy
Price Target: $31
Current: $4.17
Upside: +643.41%
Nov 14, 2024
Reiterates: Buy
Price Target: $16
Current: $3.45
Upside: +363.77%
Nov 13, 2024
Reiterates: Buy
Price Target: $47
Current: $0.91
Upside: +5,090.50%
Nov 13, 2024
Reiterates: Buy
Price Target: $6
Current: $0.86
Upside: +594.93%
Nov 11, 2024
Maintains: Buy
Price Target: $3 → $32
Current: $14.99
Upside: +113.48%
Nov 11, 2024
Reiterates: Buy
Price Target: $9
Current: $2.63
Upside: +242.21%
Nov 8, 2024
Reiterates: Buy
Price Target: $157
Current: $119.19
Upside: +31.72%
Nov 8, 2024
Reiterates: Buy
Price Target: $5.75
Current: $3.03
Upside: +89.77%
Nov 6, 2024
Reiterates: Buy
Price Target: $21
Current: $0.28
Upside: +7,451.24%
Nov 6, 2024
Reiterates: Buy
Price Target: $32
Current: $8.55
Upside: +274.27%
Nov 5, 2024
Reiterates: Buy
Price Target: $221
Current: $190.40
Upside: +16.07%
Nov 5, 2024
Maintains: Buy
Price Target: $90 → $102
Current: $52.59
Upside: +93.95%
Nov 4, 2024
Reiterates: Buy
Price Target: $17
Current: $0.96
Upside: +1,670.83%
Oct 31, 2024
Reiterates: Buy
Price Target: $40
Current: $6.44
Upside: +521.12%
Oct 29, 2024
Reiterates: Buy
Price Target: $35
Current: $3.03
Upside: +1,055.12%
Oct 25, 2024
Reiterates: Buy
Price Target: $57
Current: $26.04
Upside: +118.89%
Oct 24, 2024
Reiterates: Buy
Price Target: $37
Current: $7.53
Upside: +391.37%
Oct 23, 2024
Reiterates: Buy
Price Target: $117
Current: $30.20
Upside: +287.42%
Oct 18, 2024
Reiterates: Buy
Price Target: $18
Current: $2.38
Upside: +656.30%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $4.69
Upside: +432.59%
Sep 18, 2024
Reiterates: Buy
Price Target: $15
Current: $2.88
Upside: +420.83%
Aug 16, 2024
Reiterates: Buy
Price Target: $20
Current: $0.54
Upside: +3,571.75%
Aug 6, 2024
Reiterates: Buy
Price Target: $21
Current: $5.10
Upside: +311.76%
Aug 1, 2024
Reiterates: Buy
Price Target: $8
Current: $0.29
Upside: +2,616.47%
May 16, 2024
Reiterates: Buy
Price Target: $2
Current: $0.21
Upside: +875.13%
May 6, 2024
Reiterates: Buy
Price Target: $7
Current: $0.50
Upside: +1,289.16%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.74
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.83
Upside: +1,648.63%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $3.05
Upside: +883.61%
Mar 11, 2020
Reiterates: Buy
Price Target: $11 → $9
Current: $12.30
Upside: -26.83%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $3.31
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $35.07
Upside: -5.90%
May 30, 2017
Initiates: Buy
Price Target: $720
Current: $16.77
Upside: +4,192.18%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $4.00
Upside: +1,850.00%